The update to shareholders that came out this morning is great confirmation of the successful progress BNO is making. I'm particularly pleased with the diversity in the pipeline (105 and 210. with a second clinical study - PTSD - with 210) and, perhaps , even more pleased by the prospects of commercial transactions in the foreseeable future. Continued good progress IMO. GLTA
Add to My Watchlist
What is My Watchlist?